Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after treatment was completed, prompting the Centers for Disease Control ...
Jun 21, 2022
0
55
Few patients experience rebound of COVID-19 symptoms after nirmatrelvir/ritonavir (NM/R) treatment, according to research published online June 14 in Clinical Infectious Diseases.
Jun 17, 2022
0
22
Nearly a year after many rich nations achieved widespread vaccination against COVID-19, many less affluent countries still face difficult choices about which groups of people should be the first to receive vaccines from a ...
Jun 15, 2022
0
13
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound ...
Jun 14, 2022
0
8
An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated ...
Jun 9, 2022
0
20
Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing ...
Jun 8, 2022
0
8
Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent ...
Jun 2, 2022
0
3
The risk of being exposed to COVID-19 particles increases with shorter physical distance to a patient, higher patient viral load and poor ventilation. Measurements taken by researchers at Lund University in Sweden of airborne ...
May 11, 2022
0
4
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April) and published in the journal Clinical Infectious Diseases has found ...
Apr 21, 2022
0
18
Evidence of a relative to the bacteria that causes Lyme disease has been detected in human blood samples across New England, according to a new study led by researchers at the Yale School of Public Health.
Mar 24, 2022
1
231
